Julia Makarova

Dr. Julia Makarova

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2016 in Progress in Histochemistry and Cytochemistry
Verified
Journal Article
Closed access
JMJulia Makarova
Julia Makarova
MSMaxim Shkurnikov
Maxim Shkurnikov
DWDaniel Wicklein
Daniel Wicklein
TLTobias Lange
Tobias Lange
TSTimur R. Samatov
Timur R. Samatov
Alexander TonevitskyAlexander Tonevitsky
Alexander Tonevitsky

1 August 2021 in Trends in Biochemical Sciences
Verified
Journal Article
Closed access
JMJulia Makarova
Julia Makarova
Andrey TurchinovichAndrey Turchinovich
Andrey Turchinovich
MSMaxim Shkurnikov
Maxim Shkurnikov
Alexander TonevitskyAlexander Tonevitsky
Alexander Tonevitsky

24 November 2019 in Cells
Verified
Journal Article
Open access
PDF file
KSKurt Sartorius
Kurt Sartorius
JMJulia Makarova
Julia Makarova
Benn SartoriusBenn Sartorius
Benn Sartorius
PAPing An
Ping An
CWCheryl Winkler
Cheryl Winkler
AKAnna Kramvis
Anna Kramvis
The incidence and mortality of hepatitis B virus (HBV)-associated hepatocellular carcinoma (HBV-HCC) is an intractable public health problem in developing countries that is compounded by limited early detection and therapeutic options. Despite the early promise of utilizing the regulatory role of miRNA in liver cancer, this field remains largely in the work-in-progress phase. This exploratory review paper adopts a broad focus in order to collate evidence of the regulatory role of miRNA in each stage of the HBV-HCC continuum. This includes the regulatory role of miRNA in early HBV infection, chronic inflammation, fibrosis/cirrhosis, and the onset of HCC. The paper specifically investigates HBV dysregulated miRNA that influence the expression of the host/HBV genome in HBV-HCC pathogenesis and fully acknowledges that this does not cover the full spectrum of dysregulated miRNA. The sheer number of dysregulated miRNA in each phase support a hypothesis that future therapeutic interventions will need to consider incorporating multiple miRNA panels.

10 July 2020 in Viruses
Verified
Journal Article
Open access
PDF file
KSKurt Sartorius
Kurt Sartorius
LSLeo Swadling
Leo Swadling
PAPing An
Ping An
JMJulia Makarova
Julia Makarova
CWCheryl Winkler
Cheryl Winkler
AKAnna Kramvis
Anna Kramvis
Currently, the treatment of hepatitis B virus (HBV)-associated hepatocellular carcinoma (HCC) [HBV-HCC] relies on blunt tools that are unable to offer effective therapy for later stage pathogenesis. The potential of miRNA to treat HBV-HCC offer a more targeted approach to managing this lethal carcinoma; however, the complexity of miRNA as an ancillary regulator of the immune system remains poorly understood. This review examines the overlapping roles of HBx-dysregulated miRNA in HBV-HCC and immune pathways and seeks to demonstrate that specific miRNA response in immune cells is not independent of their expression in hepatocytes. This interplay between the two pathways may provide us with the possibility of using candidate miRNA to manipulate this interaction as a potential therapeutic option.

1 November 2007 in Biochemistry (Moscow)
Verified
Journal Article
Closed access
PDF file
JMJulia Makarova
Julia Makarova
DKDmitri Kramerov
Dmitri Kramerov
There has been substantial progress in studies on non-protein-coding RNAs (ncRNAs) during the last decade. Due to the development of new experimental approaches, a wide variety of such molecules have been found. This review considers the major groups of eukaryotic ncRNAs successfully studied in recent years. In particular, snoRNAs and scaRNAs involved in RNA modification and also miRNAs, siRNAs, tasiRNAs, and piRNAs responsible for RNA silencing are discussed. The transcripts of SINEs and SINE-like genes are considered separately.

5 February 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
VGVladimir Galatenko
Vladimir Galatenko
AGAlexey V. Galatenko
Alexey V. Galatenko
TSTimur R. Samatov
Timur R. Samatov
ATAndrey A. Turchinovich
Andrey A. Turchinovich
MSMaxim Shkurnikov
Maxim Shkurnikov
Alexander TonevitskyAlexander Tonevitsky
Alexander Tonevitsky
MicroRNAs (miRNAs) are a family of short noncoding RNAs that posttranscriptionally regulate gene expression and play an important role in multiple cellular processes. A significant percentage of miRNAs are intragenic, which is often functionally related to their host genes playing either antagonistic or synergistic roles. In this study, we constructed and analyzed the entire network of intergenic interactions induced by intragenic miRNAs. We further focused on the core of this network, which was defined as a union of nontrivial strongly connected components, i.e., sets of nodes (genes) mutually connected via directed paths. Both the entire network and its core possessed statistically significant non-random properties. Specifically, genes forming the core had high expression levels and low expression variance. Furthermore, the network core did not split into separate components corresponding to individual signalling or metabolic pathways, but integrated genes involved in key cellular processes, including DNA replication, transcription, protein homeostasis and cell metabolism. We suggest that the network core, consisting of genes mutually regulated by their intragenic miRNAs, could coordinate adjacent pathways or homeostatic control circuits, serving as a horizontal inter-circuit link. Notably, expression patterns of these genes had an efficient prognostic potential for breast and colorectal cancer patients.